Biomed Central Ltd

SHERPA: Unknown

People

  1. O'Reilly
    O'Reilly
  2. Capanu
    Capanu
  3. Chou
    Chou
  4. Romesser
    Romesser
  5. Abou-Alfa
    Abou-Alfa
  6. Basturk
    Basturk
  7. Bercz
    Bercz
  8. Desai
    Desai
  9. Diaz
    Diaz
  10. Garcia Aguilar
    Garcia Aguilar

Groups

  1. Center for Pancreatic Cancer Research (13)
  2. Department of Medicine (13)
  3. Gastrointestinal Oncology Service (13)
  4. Solid Tumor Oncology Division (13)
  5. Biostatistics Service (2)
  6. Department of Pathology and Laboratory Medicine (2)
  7. Epidemiology and Biostatistics (2)
  8. GSK Faculty (2)
  9. Melanoma and Immunotherapeutics Service (2)
  10. Radiation Oncology, Department of (2)
Search Within
  1. "Eileen O'Reilly"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (3)
Groups
  1. Center for Pancreatic Cancer Research (13)
  2. Department of Medicine (13)
  3. Gastrointestinal Oncology Service (13)
  4. Solid Tumor Oncology Division (13)
  5. Biostatistics Service (2)
  6. Department of Pathology and Laboratory Medicine (2)

More Groups

People
  1. Eileen O'Reilly (13)
  2. Joanne Chou (2)
  3. Marinela Capanu (2)
  4. Paul Romesser (2)
  5. Anna Varghese (1)
  6. Aron Bercz (1)

More People

Years
  1. 2024 (3)
  2. 2022 (1)
  3. 2021 (2)
  4. 2019 (1)
  5. 2018 (3)
  6. 2017 (2)

More Years

Publications
  1. BMC Cancer (6)
  2. Journal for ImmunoTherapy of Cancer (5)
  3. World Journal of Surgical Oncology (2)

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer
    Journal Article

    Alvarez, J. A.; Shi, Q.; Dasari, A.; Garcia-Aguilar, J.; Sanoff, H.; George, T. J.; Hong, T.; Yothers, G.; Philip, P.; Nelson, G.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
    Journal Article

    Callahan, M.; Amin, A.; Kaye, F. J.; Morse, M. A.; Taylor, M. H.; Peltola, K. J.; Sharma, P.; O'Reilly, E. M.; Meadows Shropshire, S.; O'Brien, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
    Journal Article

    Hitchcock, K. E.; Miller, E. D.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; George, M.; Jee, K. W.; more...
    BMC Cancer (2024)

    Fulltext@MSK | Save
  • Exploratory platform trial to evaluate immunotherapy combinations with chemotherapy for the treatment of patients with previously untreated metastatic pancreatic adenocarcinoma (REVOLUTION)
    Meeting Abstract

    Lyman, J.; O'Reilly, E.; Wainberg, Z.; Fisher, G.; Wolff, R.; Ko, A.; O'Hara, M.; Singh, H.; Amaravadi, R.; Kimmelman, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Multiomic biomarker signatures identify subsets of patients who may benefit from either nivolumab or sotigalimab in combination with chemotherapy in metastatic pancreatic cancer
    Meeting Abstract

    Maurer, D.; Yu, J. X.; Sklodowski, K.; Tognetti, M.; Reiter, L.; Bruderer, R.; Vowinckel, J.; Pfeiffer, S.; O'Hara, M.; O'Reilly, E.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
    Journal Article

    Askan, G.; Sahin, I. H.; Chou, J. F.; Yavas, A.; Capanu, M.; Iacobuzio-Donahue, C. A.; Basturk, O.; O’Reilly, E. M.
    BMC Cancer (2021)

    Fulltext@MSK | Save
  • A phase 1/2 study of GB1275, a novel CD11b modulator, as monotherapy and with an anti-PD-1 antibody in specified advanced solid tumors or with chemotherapy in metastatic pancreatic cancer (mPDAC)
    Meeting Abstract

    Bendell, J.; Rasco, D.; Park, W.; Zhou, L.; Galkin, A.; Slee, D.; Carter, L.; Nickle, D.; Tran, R.; Li, J.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Acquired resistance to immunotherapy in MMR-D pancreatic cancer
    Journal Article

    Hu, Z. I.; Hellmann, M. D.; Wolchok, J. D.; Vyas, M.; Shia, J.; Stadler, Z. K.; Diaz, L. A. Jr; O'Reilly, E. M.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Pancreatic adenocarcinoma: Insights into patterns of recurrence and disease behavior
    Journal Article

    Sahin, I. H.; Elias, H.; Chou, J. F.; Capanu, M.; O'Reilly, E. M.
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
    Journal Article

    Glassman, D. C.; Palmaira, R. L.; Covington, C. M.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    BMC Cancer (2018)

    Fulltext@MSK | Save